Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Revive Therapeutics Ltd C.RVV

Alternate Symbol(s):  RVVTF

Revive Therapeutics Ltd. is a Canada-based life sciences company. The Company is focused on the research and development of therapeutics and diagnostics for infectious diseases, medical countermeasures, and rare disorders. It is engaged in exploring the use of Bucillamine for the potential treatment of nerve agent exposure and long COVID. The Company, through its diagnostics division, is evaluating a point-of-care in vitro diagnostic device that aids in the detection of post COVID-19 conditions or Long COVID. It also advancing the development of Psilocybin-based therapeutics through various programs. The Company's subsidiaries include Revive Therapeutics Inc. (Ontario), Revive Diagnostics Inc., and Psilocin Pharma Corp. (Ontario).


CSE:RVV - Post by User

Bullboard Posts
Comment by hcahoonon Jun 29, 2018 7:34pm
125 Views
Post# 28254615

RE:Financing at 21 cents?

RE:Financing at 21 cents?
Easy to Hate The Way Revive Trades - But Good Risk Here
 
June 29, 2018 - 8:20 am MST
 

Revive Therapeutics (RVV:TSXV 20 cents / RVVTF:OTCQB)
 

After the Orphan Drug Status approval this week, RVV cycled great volume in the high 0.20's.... but this trading is seriously messed up.

I don't know if they are planning to announce a financing in this range and those who will participate are dumping stock to fund that. Or are shareholders so tired of this CEO that when rallies fail, they just dump their paper? Its really hard to tell what is wrong with this company.

I know that companies who apply for and get an FDA Orphan Drug designation, are NOT pump and dumps. Especially when they received it on science associated with Cannabis - a schedule 1 drug in the United States. That is not going to happen every day. Fundamentally this is solid - or at least it appears so. BUT it trades horrible !

I am convinced there is really good value near 20 cents and mid next week I will explain why. But go through their corporate presentation. Its neat science and in light of the ongoing frustrations with the way this stock trades, I think RVV offers very attractive risk/reward from this level.

Publicly traded Canadian marijuana stocks are commanding huge valuations and many have a LOT of cash. It would make sense that they start to take more of an interest in the science side of this business and will be looking to acquire companies like Revive (even if its in 2019).

Revive Corporate Presentation:
Bullboard Posts